{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:55:44Z","timestamp":1793368544600,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.eclinm.2023.102143","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T07:28:16Z","timestamp":1691479696000},"page":"102143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006\u201319: a national, retrospective cohort study"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1277-9600","authenticated-orcid":false,"given":"Ali","family":"Abdelhay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0630-1117","authenticated-orcid":false,"given":"Amir A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Orakzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Jamshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eclinm.2023.102143_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102143_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102143_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/pbc.25308","article-title":"Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden","volume":"62","author":"Meeths","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.eclinm.2023.102143_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cyto.2017.03.013","article-title":"Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis","volume":"97","author":"Luo","year":"2017","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102143_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08880018.2013.858198","article-title":"Risk factors for early fatal outcomes among children with hemophagocytic lymphohistiocytosis (HLH): a single-institution case-series in Vietnam","volume":"31","author":"Dao","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib7","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1097\/MPH.0000000000002283","article-title":"Clinical features and prognostic factors of early outcome in paediatric hemophagocytic lymphohistiocytosis: a retrospective analysis of 227 cases","volume":"44","author":"Zhou","year":"2022","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.eclinm.2023.102143_bib8","first-page":"69","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George","year":"2014","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.eclinm.2023.102143_bib9","article-title":"A\u00a0study on early death prognosis model in adult patients with secondary hemophagocytic lymphohistiocytosis","volume":"2022","author":"Zhang","year":"2022","journal-title":"J\u00a0Healthc Eng"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102143_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mayocpiqo.2018.06.006","article-title":"Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis","volume":"2","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"4","key":"10.1016\/j.eclinm.2023.102143_bib11","first-page":"149","article-title":"Hemophagocytic lymphohistiocytosis in adults: associated diagnoses and outcomes, a ten-year experience at a single institution","volume":"8","author":"Jumic","year":"2019","journal-title":"J\u00a0Hematol"},{"issue":"15","key":"10.1016\/j.eclinm.2023.102143_bib12","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"issue":"9927","key":"10.1016\/j.eclinm.2023.102143_bib13","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.102143_bib14","series-title":"Healthcare cost and utilization project (HCUP). Introduction to the HCUP national inpatient sample (NIS) 2019","year":"2019"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2018-000337","article-title":"Retrospective study of haemophagocytic syndrome hospitalisations in children in the USA","volume":"2","author":"Badheka","year":"2018","journal-title":"BMJ Paediatr Open"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib16","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/RHU.0000000000001670","article-title":"Hemophagocytic lymphohistiocytosis hospitalizations in adults and its association with rheumatologic diseases: data from nationwide inpatient sample","volume":"28","author":"Patel","year":"2022","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102143_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000797","article-title":"Temporal trends in the incidence of hemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018","volume":"6","author":"West","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.eclinm.2023.102143_bib19","series-title":"Joinpoint regression program. Version 4.9.1","year":"2022"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102143_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"9596","key":"10.1016\/j.eclinm.2023.102143_bib21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102143_bib22","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102143_bib23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","article-title":"Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and paediatric patients","volume":"145","author":"Debaugnies","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"17","key":"10.1016\/j.eclinm.2023.102143_bib24","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.eclinm.2023.102143_bib25","first-page":"5799","article-title":"Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases","volume":"11","author":"Baverez","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.eclinm.2023.102143_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.eclinm.2023.102143_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10875-017-0439-x","article-title":"A\u00a0personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults","volume":"37","author":"Kumar","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"issue":"9","key":"10.1016\/j.eclinm.2023.102143_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/0885066617711386","article-title":"Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis","volume":"34","author":"Wohlfarth","year":"2019","journal-title":"J\u00a0Intensive Care Med"},{"issue":"Suppl","key":"10.1016\/j.eclinm.2023.102143_bib29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/01.HS9.0000847836.30971.66","article-title":"P1243: ruxolitinib combined with dexamethasone in adult patients with newly diagnosed hemophagocytic lymphohistiocytosis: interim analysis of a prospective, single-center, single-arm, phase 2 clinical trial","volume":"6","author":"Zhou","year":"2022","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"10.1016\/j.eclinm.2023.102143_bib31","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.eclinm.2023.102143_bib32","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/qjmed\/hcx183","article-title":"Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis","volume":"111","author":"Zhou","year":"2018","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.eclinm.2023.102143_bib34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock","year":"2015","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.eclinm.2023.102143_bib35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review","volume":"30","author":"Hayden","year":"2016","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2023.102143_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13054-020-02941-3","article-title":"Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore","volume":"24","author":"Knaak","year":"2020","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.eclinm.2023.102143_bib37","doi-asserted-by":"crossref","first-page":"e1137","DOI":"10.1097\/CCM.0000000000004581","article-title":"Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis","volume":"48","author":"Knaak","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eclinm.2023.102143_bib38","series-title":"Comorbidities associated with adult inpatient stays, 2019","author":"Owens","year":"2022"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023003206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023003206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:21:00Z","timestamp":1762899660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023003206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S2589537023003206"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102143","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006\u201319: a national, retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102143"}}